Difficulty: Medium
Average Score: 64%
Practice
A client has just received an allogenic bone marrow transplant as treatment for non-Hodgkin's lymphoma. The client is showing signs of rejection. What is this term called?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Graft versus host disease. Graft versus host disease (GVHD) occurs when the transplanted donor cells recognize the recipient's body as foreign and attack it. This immune response can manifest as various symptoms, including skin rash, gastrointestinal issues, and liver problems.
Option A) Lymphoma relapse is incorrect because it refers to the return of cancer cells after a period of remission, not rejection of the transplant.
Option B) Short remission is incorrect as it does not relate to the immune response following a bone marrow transplant.
Option C) Bone marrow transplant rejection is also incorrect because rejection typically involves the recipient's immune system attacking the donor cells, not vice versa.
Educationally, understanding GVHD is crucial for healthcare providers managing patients post-bone marrow transplant. Recognizing the signs and symptoms early can lead to prompt intervention and better outcomes for the patient. It highlights the complex interplay between the donor and recipient immune systems in transplantation, emphasizing the importance of monitoring and managing immune responses in these patients.
Option A) Lymphoma relapse is incorrect because it refers to the return of cancer cells after a period of remission, not rejection of the transplant.
Option B) Short remission is incorrect as it does not relate to the immune response following a bone marrow transplant.
Option C) Bone marrow transplant rejection is also incorrect because rejection typically involves the recipient's immune system attacking the donor cells, not vice versa.
Educationally, understanding GVHD is crucial for healthcare providers managing patients post-bone marrow transplant. Recognizing the signs and symptoms early can lead to prompt intervention and better outcomes for the patient. It highlights the complex interplay between the donor and recipient immune systems in transplantation, emphasizing the importance of monitoring and managing immune responses in these patients.